Aimed Alliance Comments on the CMS FY 2025 Physician Fee Schedule
On September 9, 2024, Aimed Alliance submitted a comment on the Centers for Medicare &…
Browsing: State
Maryland PDAB Approves UPL Action Plan and Updated Cost Review Regulations
At its September 10th meeting, the Maryland Prescription Drug Affordability Board (PDAB) approved its upper…
Colorado PDAB’s September Meeting: Updates on Affordability Review and UPL Rulemaking
On September 6, 2024, the Colorado Prescription Drug Affordability Board (PDAB) and Prescription Drug Affordability…
Aimed Alliance Urges Illinois to Implement Alternative Legislative Reforms to PDABs
On September 3, 2024, Aimed Alliance sent letters to Illinois Senate Majority Leader Kimberly Lightford…
Aimed Alliance Receives Interim Response to FDA Citizen Petition
On August, 28, 2024, Aimed Alliance received an interim response from the Food and Drug…
Aimed Alliance to Speak at the Ohio Rare Disease Summit
Aimed Alliance’s Counsel, Ashira Vantrees, will be speaking to employers at the Ohio Rare Disease…
Aimed Alliance Urges CT Governor to Consider PDAB Alternatives
On August 27, 2024, Aimed Alliance sent Connecticut Governor Ned Lamont a letter urging the…
Aimed Alliance Publishes New Resource on PDAB & IRA Implications for Rare Disorders
On August 20, 2024, Aimed Alliance released a new fact sheet on, “IRA, PDABs, &…
Analysis Indicates Rising Costs for ACA Plans in 2025
A new analysis released by KFF Health System Tracker found that insurers participating in ACA-regulated…
New Study Shows Importance of Clear Prescription Drug Ads
According to a new study conducted by the Food & Drug Administration’s Center for Drug…